Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Heliyon|October 2, 2020
On various Riesz-dual sequences for Schauder framesAli Reza Neisi, Mohammad Sadegh Asgari
Scientific Reports|January 30, 2025
Rational design, synthesis, in vitro, and in-silico studies of pyrazole‑phthalazine hybrids as new α‑glucosidase inhibitorsMehrdad Roshan, Roghieh Mirzazadeh, Azadeh Tajmir-Riahi, et al.
Bioorganic & Medicinal Chemistry|November 5, 2019
Design, synthesis, in vitro, and in silico studies of novel diarylimidazole-1,2,3-triazole hybrids as potent α-glucosidase inhibitorsMina Saeedi, Maryam Mohammadi-Khanaposhtani, Mohammad Sadegh Asgari, et al.
Scientific Reports|May 20, 2021
Arylmethylene hydrazine derivatives containing 1,3-dimethylbarbituric moiety as novel urease inhibitorsKeyvan Pedrood, Homa Azizian, Mohammad Nazari Montazer, et al.
International Journal of Biological Macromolecules|December 22, 2020
Design, synthesis, characterization, enzymatic inhibition evaluations, and docking study of novel quinazolinone derivativesKeyvan Pedrood, Maedeh Sherafati, Maryam Mohammadi-Khanaposhtani, et al.
Bioorganic & Medicinal Chemistry|February 28, 2021
The natural-based optimization of kojic acid conjugated to different thio-quinazolinones as potential anti-melanogenesis agents with tyrosinase inhibitory activityNima Sepehri, Aida Iraji, Ali Yavari, et al.
Molecular Diversity|March 20, 2020
Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studiesMohammad Sadegh Asgari, Maryam Mohammadi-Khanaposhtani, Zeinab Sharafi, et al.
Bioorganic Chemistry|August 25, 2019
Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studiesMohammad Sadegh Asgari, Maryam Mohammadi-Khanaposhtani, Mitra Kiani, et al.
Molecular Diversity|September 13, 2021
Design and synthesis of phenoxymethybenzoimidazole incorporating different aryl thiazole-triazole acetamide derivatives as α-glycosidase inhibitorsAnita Nasli Esfahani, Aida Iraji, Amir Alamir, et al.
Bioorganic Chemistry|February 20, 2021
Quinazolinone-dihydropyrano[3,2-b]pyran hybrids as new α-glucosidase inhibitors: Design, synthesis, enzymatic inhibition, docking study and prediction of pharmacokineticMaedeh Sherafati, Roghieh Mirzazadeh, Ebrahim Barzegari, et al.
Pageof 2